VERTEX PHARMACEUTICALS INC / MA Increase (Decrease) in Prepaid Expense and Other Assets
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$122.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-04
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $51.40M, a 32.72% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$173.40M, a 717.08% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $250.60M, a 52.25% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $40.90M.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in prepaid expense and other assets for fiscal 2025 was $396.00M, a 97.70% increase from fiscal 2024.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in prepaid expense and other assets for fiscal 2024 was $200.30M, a 63.29% decline from fiscal 2023.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in prepaid expense and other assets for fiscal 2023 was $545.70M, a 67.19% increase from fiscal 2022.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in prepaid expense and other assets for fiscal 2022 was $326.40M, a 255.56% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $51.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$122.00M 10-Q · filed 2026-08-04 | $128.60M derived: sum of 3 quarters · filed 2026-08-04 | $169.50M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | -$173.40M 10-Q · filed 2026-05-05 | $77.20M derived: sum of 2 quarters · filed 2026-05-05 | $118.10M derived: sum of 3 quarters · filed 2026-05-05 | $194.50M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $250.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $291.50M derived: sum of 2 quarters · filed 2026-02-13 | $367.90M derived: sum of 3 quarters · filed 2026-08-04 | $396.00M 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | $40.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $117.30M derived: sum of 2 quarters · filed 2026-08-04 | $145.40M 10-Q · filed 2025-11-04 | $310.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $76.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $104.50M 10-Q · filed 2026-08-04 | $269.10M derived: sum of 3 quarters · filed 2026-08-04 | $248.10M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $28.10M 10-Q · filed 2026-05-05 | $192.70M derived: sum of 2 quarters · filed 2026-05-05 | $171.70M derived: sum of 3 quarters · filed 2026-05-05 | $327.60M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $164.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $143.60M derived: sum of 2 quarters · filed 2026-02-13 | $299.50M derived: sum of 3 quarters · filed 2026-02-13 | $200.30M 10-K · filed 2026-02-13 | ||||
| 2024-09-30 | -$21.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $134.90M derived: sum of 2 quarters · filed 2025-11-04 | $35.70M 10-Q · filed 2025-11-04 | $487.00M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-06-30 | $155.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $56.70M 10-Q · filed 2025-08-05 | $508.00M derived: sum of 3 quarters · filed 2026-02-13 | $629.00M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-03-31 | -$99.20M 10-Q · filed 2025-05-06 | $352.10M derived: sum of 2 quarters · filed 2026-02-13 | $473.10M derived: sum of 3 quarters · filed 2026-02-13 | $492.70M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2023-12-31 | $451.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $572.30M derived: sum of 2 quarters · filed 2026-02-13 | $591.90M derived: sum of 3 quarters · filed 2026-02-13 | $545.70M 10-K · filed 2026-02-13 | ||||
| 2023-09-30 | $121.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $140.60M derived: sum of 2 quarters · filed 2024-11-05 | $94.40M 10-Q · filed 2024-11-05 | $378.90M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $19.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$26.60M 10-Q · filed 2024-08-02 | $257.90M derived: sum of 3 quarters · filed 2025-02-13 | $385.10M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | -$46.20M 10-Q · filed 2024-05-07 | $238.30M derived: sum of 2 quarters · filed 2025-02-13 | $365.50M derived: sum of 3 quarters · filed 2025-02-13 | $347.80M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | $284.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $411.70M derived: sum of 2 quarters · filed 2025-02-13 | $394.00M derived: sum of 3 quarters · filed 2025-02-13 | $326.40M 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | $127.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $109.50M derived: sum of 2 quarters · filed 2023-11-07 | $41.90M 10-Q · filed 2023-11-07 | $26.00M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | -$17.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$85.30M 10-Q · filed 2023-08-02 | -$101.20M derived: sum of 3 quarters · filed 2024-02-15 | -$85.70M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | -$67.60M 10-Q · filed 2023-05-02 | -$83.50M derived: sum of 2 quarters · filed 2024-02-15 | -$68.00M derived: sum of 3 quarters · filed 2024-02-15 | $10.90M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | -$15.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | -$400.00K derived: sum of 2 quarters · filed 2024-02-15 | $78.50M derived: sum of 3 quarters · filed 2024-02-15 | $91.80M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $15.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $94.40M derived: sum of 2 quarters · filed 2022-10-28 | $107.70M 10-Q · filed 2022-10-28 | $107.67M 10-Q · filed 2021-11-03 | $140.39M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2021-06-30 | $78.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $92.20M 10-Q · filed 2022-08-05 | $92.19M 10-Q · filed 2021-07-30 | $124.89M derived: sum of 3 quarters · filed 2023-02-10 | $360.88M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2021-03-31 | $13.30M 10-Q · filed 2022-05-06 | $13.32M 10-Q · filed 2021-04-30 | $45.99M derived: sum of 2 quarters · filed 2023-02-10 | $281.98M derived: sum of 3 quarters · filed 2023-02-10 | $313.69M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2020-12-31 | $32.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $268.68M derived: sum of 2 quarters · filed 2023-02-10 | $300.39M derived: sum of 3 quarters · filed 2023-02-10 | $297.60M 10-K · filed 2023-02-10 | $297.56M 10-K · filed 2021-02-11 | |||
| 2020-09-30 | $235.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $267.70M derived: sum of 2 quarters · filed 2021-11-03 | $264.91M 10-Q · filed 2021-11-03 | $205.80M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-06-30 | $31.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $28.92M 10-Q · filed 2021-07-30 | -$30.19M derived: sum of 3 quarters · filed 2022-02-09 | -$24.06M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-03-31 | -$2.79M 10-Q · filed 2021-04-30 | -$61.90M derived: sum of 2 quarters · filed 2022-02-09 | -$55.77M derived: sum of 3 quarters · filed 2022-02-09 | -$30.25M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2019-12-31 | -$59.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | -$52.98M derived: sum of 2 quarters · filed 2022-02-09 | -$27.46M derived: sum of 3 quarters · filed 2022-02-09 | -$35.40M 10-K · filed 2022-02-09 | -$35.44M 10-K · filed 2020-02-13 | |||
| 2019-09-30 | $6.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $31.65M derived: sum of 2 quarters · filed 2020-10-30 | $23.71M 10-Q · filed 2020-10-30 | $38.82M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | $25.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $17.58M 10-Q · filed 2020-07-31 | $32.69M derived: sum of 3 quarters · filed 2021-02-11 | $34.30M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | -$7.94M 10-Q · filed 2020-05-01 | $7.17M derived: sum of 2 quarters · filed 2021-02-11 | $8.78M derived: sum of 3 quarters · filed 2021-02-11 | $857.00K derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | $15.11M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $16.72M derived: sum of 2 quarters · filed 2021-02-11 | $8.80M derived: sum of 3 quarters · filed 2021-02-11 | -$16.68M 10-K · filed 2021-02-11 | ||||
| 2018-09-30 | $1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$6.32M derived: sum of 2 quarters · filed 2019-10-31 | -$31.80M 10-Q · filed 2019-10-31 | -$5.03M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | -$7.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$33.41M 10-Q · filed 2019-08-01 | -$6.64M derived: sum of 3 quarters · filed 2020-02-13 | $38.12M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | -$25.48M 10-Q · filed 2019-05-01 | $1.28M derived: sum of 2 quarters · filed 2020-02-13 | $46.05M derived: sum of 3 quarters · filed 2020-02-13 | $41.08M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $26.77M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $71.53M derived: sum of 2 quarters · filed 2020-02-13 | $66.56M derived: sum of 3 quarters · filed 2020-02-13 | $111.06M 10-K · filed 2020-02-13 | ||||
| 2017-09-30 | $44.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $39.80M derived: sum of 2 quarters · filed 2018-10-25 | $84.30M 10-Q · filed 2018-10-25 | $90.01M 10-Q · filed 2017-10-30 | $77.95M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2017-06-30 | -$4.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $39.53M 10-Q · filed 2018-07-26 | $47.85M 10-Q · filed 2017-07-28 | $33.18M derived: sum of 3 quarters · filed 2019-02-13 | $34.19M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2017-03-31 | $44.50M 10-Q · filed 2018-04-27 | $47.18M 10-Q · filed 2017-04-28 | $38.15M derived: sum of 2 quarters · filed 2019-02-13 | $39.16M derived: sum of 3 quarters · filed 2019-02-13 | $39.80M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2016-12-31 | -$6.35M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | -$5.34M derived: sum of 2 quarters · filed 2019-02-13 | -$4.69M derived: sum of 3 quarters · filed 2019-02-13 | $2.63M 10-K · filed 2019-02-13 | $8.70M 10-K · filed 2017-02-23 | |||
| 2016-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-30 | $1.65M derived: sum of 2 quarters · filed 2017-10-30 | $8.98M 10-Q · filed 2017-10-30 | -$10.75M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | $646.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $7.97M 10-Q · filed 2017-07-28 | -$11.76M derived: sum of 3 quarters · filed 2018-02-15 | -$3.42M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | $7.33M 10-Q · filed 2017-04-28 | -$12.40M derived: sum of 2 quarters · filed 2018-02-15 | -$4.06M derived: sum of 3 quarters · filed 2018-02-15 | -$3.90M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | -$19.73M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | -$11.39M derived: sum of 2 quarters · filed 2018-02-15 | -$11.22M derived: sum of 3 quarters · filed 2018-02-15 | $4.01M 10-K · filed 2018-02-15 | $9.26M 10-K · filed 2016-02-16 | |||
| 2015-09-30 | $8.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $8.50M derived: sum of 2 quarters · filed 2016-10-31 | $23.74M 10-Q · filed 2016-10-31 | $20.40M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $164.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $15.40M 10-Q · filed 2016-08-01 | $12.06M derived: sum of 3 quarters · filed 2017-02-23 | $13.63M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-31 | $15.23M 10-Q · filed 2016-05-03 | $11.89M derived: sum of 2 quarters · filed 2017-02-23 | $13.47M derived: sum of 3 quarters · filed 2017-02-23 | $13.07M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | -$3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$1.77M derived: sum of 2 quarters · filed 2017-02-23 | -$2.17M derived: sum of 3 quarters · filed 2017-02-23 | $15.77M 10-K · filed 2017-02-23 | ||||
| 2014-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $1.17M derived: sum of 2 quarters · filed 2015-10-30 | $19.11M 10-Q · filed 2015-10-30 | $14.69M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-06-30 | -$399.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $17.54M 10-Q · filed 2015-08-04 | $13.12M derived: sum of 3 quarters · filed 2016-02-16 | $11.45M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-03-31 | $17.94M 10-Q · filed 2015-05-04 | $13.52M derived: sum of 2 quarters · filed 2016-02-16 | $11.85M derived: sum of 3 quarters · filed 2016-02-16 | $5.01M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2013-12-31 | -$4.42M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-16 | -$6.09M derived: sum of 2 quarters · filed 2016-02-16 | -$12.93M derived: sum of 3 quarters · filed 2016-02-16 | $12.06M 10-K · filed 2016-02-16 | ||||
| 2013-09-30 | -$1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$8.51M derived: sum of 2 quarters · filed 2014-11-06 | $16.48M 10-Q · filed 2014-11-06 | $17.40M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-06-30 | -$6.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $18.15M 10-Q · filed 2014-07-31 | $19.07M derived: sum of 3 quarters · filed 2015-02-13 | $1.72M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-03-31 | $24.99M 10-Q · filed 2014-05-05 | $25.91M derived: sum of 2 quarters · filed 2015-02-13 | $8.55M derived: sum of 3 quarters · filed 2015-02-13 | $28.06M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2012-12-31 | $921.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$16.43M derived: sum of 2 quarters · filed 2015-02-13 | $3.08M derived: sum of 3 quarters · filed 2015-02-13 | $23.62M 10-K · filed 2015-02-13 | $12.26M 10-K · filed 2013-03-01 | |||
| 2012-09-30 | -$17.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $2.16M derived: sum of 2 quarters · filed 2013-11-07 | $22.70M 10-Q · filed 2013-11-07 | $2.29M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-06-30 | $19.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $40.05M 10-Q · filed 2013-08-02 | $28.18M 10-Q · filed 2012-08-08 | $19.64M derived: sum of 3 quarters · filed 2014-02-11 | $21.00M derived: sum of 4 quarters · filed 2014-02-11 | |||
| 2012-03-31 | $20.54M 10-Q · filed 2013-05-08 | $130.00K derived: sum of 2 quarters · filed 2014-02-11 | $1.49M derived: sum of 3 quarters · filed 2014-02-11 | -$2.80M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2011-12-31 | -$20.41M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | -$19.05M derived: sum of 2 quarters · filed 2014-02-11 | -$23.34M derived: sum of 3 quarters · filed 2014-02-11 | -$10.36M 10-K · filed 2014-02-11 | $1.72M 10-K · filed 2012-02-22 | |||
| 2011-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | -$2.93M derived: sum of 2 quarters · filed 2012-11-06 | $10.05M 10-Q · filed 2012-11-06 | $4.70M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | -$4.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $8.69M 10-Q · filed 2012-08-08 | $3.34M derived: sum of 3 quarters · filed 2013-03-01 | -$108.00K derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-03-31 | $12.98M 10-Q · filed 2012-05-10 | $7.62M derived: sum of 2 quarters · filed 2013-03-01 | $4.18M derived: sum of 3 quarters · filed 2013-03-01 | -$88.00K derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2010-12-31 | -$5.36M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | -$8.80M derived: sum of 2 quarters · filed 2013-03-01 | -$13.07M derived: sum of 3 quarters · filed 2013-03-01 | $600.00K 10-K · filed 2013-03-01 | ||||
| 2010-09-30 | -$3.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$7.71M derived: sum of 2 quarters · filed 2011-11-03 | $5.96M 10-Q · filed 2011-11-03 | $3.88M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-06-30 | -$4.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $9.40M 10-Q · filed 2011-08-09 | $7.33M derived: sum of 3 quarters · filed 2012-02-22 | $7.22M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-03-31 | $13.67M 10-Q · filed 2011-05-06 | $11.60M derived: sum of 2 quarters · filed 2012-02-22 | $11.49M derived: sum of 3 quarters · filed 2012-02-22 | $8.34M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2009-12-31 | -$2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | -$2.17M derived: sum of 2 quarters · filed 2012-02-22 | -$5.32M derived: sum of 3 quarters · filed 2012-02-22 | -$2.07M 10-K · filed 2012-02-22 | ||||
| 2009-09-30 | -$103.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | -$3.25M derived: sum of 2 quarters · filed 2010-10-28 | $2.00K 10-Q · filed 2010-10-28 | |||||
| 2009-06-30 | -$3.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-03 | $105.00K 10-Q · filed 2010-08-03 | ||||||
| 2009-03-31 | $3.25M 10-Q · filed 2010-05-03 | |||||||
| 2008-12-31 | $7.33M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |